Cellular and morphological changes in lymphoid organs after a single injection of interleukin 1α in the mouse

[1]  M. Krönke,et al.  Mechanisms of tumor necrosis factor action. , 1992, Seminars in oncology.

[2]  D. Williams,et al.  Alterations in megakaryocyte and platelet compartments following in vivo IL-1 beta administration to normal mice. , 1989, Journal of immunology.

[3]  P. Furmanski,et al.  In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. , 1989, Blood.

[4]  K. McIntyre,et al.  Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha , 1989, Infection and immunity.

[5]  C. Dinarello,et al.  Interleukin-1 and the response to injury , 1989, Immunologic research.

[6]  T. Ulich,et al.  The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation. , 1989, The American journal of pathology.

[7]  S. Vukicevic,et al.  Immunosuppression induced by talc granulomatosis in the rat. , 1988, Clinical and experimental immunology.

[8]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[9]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[10]  W. Robinson,et al.  Interleukin-1 enhances murine granulopoiesis in vivo. , 1988, Experimental hematology.

[11]  T. Ulich,et al.  Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. , 1987, Journal of immunology.